Bone Histomorphometry, Microarchitecture, and Matrix Structure in Patients Receiving Risedronate Daily or Weekly.
Phase of Trial: Phase IV
Latest Information Update: 24 Mar 2010
At a glance
- Drugs Risedronic acid (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- Sponsors Procter & Gamble
- 24 Mar 2010 Company added as trial sponsor as reported by ClinicalTrials.gov.
- 11 Feb 2009 New trial record